HCG – Bodybuilders to TRT – Side Effects, Properties, and Uses

Human chorionic gonadotropin, often shortened to hCG, is presented as a long‑standing hormone therapy with evolving uses. It is described as historically used by bodybuilders on cycle and during post‑cycle recovery after stopping anabolic steroids. The discussion also notes use in men with low testosterone and in cases of anabolic steroid–induced hypogonadism. A short history follows, describing discovery in the 1920s and medical introduction in the early 1930s. Early manufacturing methods are described, including pituitary extracts and later purification from the urine of pregnant women. The presenter highlights that older medical literature listed many indications that are no longer accepted today. He stresses that modern prescribing has become more restricted and focused on fertility‑related indications.

The talk then shifts to pharmacology, describing hCG as a placental glycoprotein hormone with alpha and beta subunits. It is explained that the alpha portion resembles other pituitary hormones, while the beta portion drives hCG’s unique activity. The effect is framed as mimicking luteinizing hormone, stimulating Leydig cells and supporting testicular testosterone production. Differences in injection routes are discussed, with intramuscular dosing described as shorter acting than subcutaneous dosing. Because conclusive comparative studies are limited, dosing route is described as individualized and dependent on dose size. In performance‑drug contexts, hCG is described as a way to bypass suppressed pituitary signaling during steroid exposure. The presenter emphasizes that this does not restart the brain’s axis directly, but instead stimulates the testes downstream.

When hCG is combined with testosterone therapy, the presenter describes a debate about long‑term cell desensitization. He notes that some men report that testicular size support diminishes over time, even when doses are increased. Potential side effects are described, including systemic water retention and increased aromatization leading to higher estradiol. He also mentions observing possible cortisol or adrenal‑related changes in some laboratory patterns, while noting uncertainty. For men coming off steroids or aiming for fertility, he references newer physician literature discussing higher short‑term doses. He shares a practical preference for simpler, shorter courses and avoiding unnecessarily high dosing whenever possible. The closing message is that hCG can be valuable for fertility and recovery, but requires careful individual medical oversight.